Table 1.
Patient demographics and adjuvant therapy data
| No. | Age | Sex | Tumor size (cm) | Histologic diagnosis | Chemotherapy | Radiotherapy | Local recurrence | Metastasis | Oncologic outcome | Follow-up period (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 43 | M | 11 | Osteosarcoma | Preoperative/postoperative | None | Yes | Yes | DOD | 23 |
| 2 | 14 | M | 5 | Ewing’s sarcoma | Preoperative/postoperative | Preoperative | No | Yes | DOD | 3 |
| 3 | 18 | F | 6 | Metastatic osteosarcoma | Preoperative/postoperative | None | Yes | Yes | DOD | 33 |
| 4 | 52 | F | 12 | Chondrosarcoma (grade 1) | None | None | No | No | CDF | 131 |
| 5 | 32 | M | 13 | Chondrosarcoma (grade 1) | None | None | No | No | CDF | 126 |
| 6 | 44 | M | 14 | Chondrosarcoma (grade 1) | None | None | No | No | CDF | 96 |
| 7 | 36 | M | 12 | Chondrosarcoma (grade 1) | None | None | No | No | CDF | 63 |
| 8 | 14 | F | 10 | Ewing’s sarcoma | Preoperative/postoperative | None | No | Yes | NED | 16 |
| 9 | 10 | F | 7 | Ewing’s sarcoma | Preoperative/postoperative | Postoperative | No | No | CDF | 7 |
DOD dead of disease, CDF continuously disease-free, NED no evidence of disease